11
Oct

Prolotherapy – Non-surgical solutions to osteoarthritis

Sometimes called degenerative joint disease or degenerative arthritis, osteoarthritis (OA) is the most common chronic condition of the joints. OA is a progressive disease. Symptoms worsen over time. There is no cure, but treatments like Prolotherapy,  Platelet-Rich Plasma (PRP) and Viscosupplement can help the individual control pain and swelling, and stay mobile and active.

What is Prolotherapy?

Prolotherapy is an injection procedure used to treat connective tissue injuries of the musculoskeletal system that have not healed by either rest or other nonsurgical therapies in order to relieve back pain. The injections promote a healing response in small tears and weakened tissue, with the goal of alleviating back pain and improving function. Prolotherapy is also referred to as sclerosant therapy, sclerotherapy, regenerative injection therapy, “proliferative” injection therapy, and nonsurgical ligament reconstruction.

Prolotherapy has been used in pain management and treatment of numerous conditions, including back pain and neck pain due to spine related conditions such as:

  • Degenerative disc disease
  • Sacroiliac problems
  • Sciatica
  • Whiplash
How does Prolotherapy work?

Prolotherapy works by causing a temporary, low-grade inflammation at the injection site, activating fibroblasts to the area, which, in turn, synthesize precursors to mature collagen and thus reinforce connective tissue. It has been well documented that direct exposure of fibroblasts to growth factors (either endogenous or exogenous) causes new cell growth and collagen deposition. Inflammation creates secondary growth factor elevation. The inflammatory stimulus of Prolotherapy raises the level of growth factors to resume or initiate a new connective tissue repair sequence which had prematurely aborted or never started.

Should you be experiencing pain and discomfort from osteoarthritis, we highly encourage you to talk to Dr Darryl Chew to discover the best treatment for you. Click here to contact us.